This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Foreman, C Articles by West, L Search for Related Content PubMed PubMed Citation Articles by Foreman, C Articles by West, L Pubmed/NCBI databases Medline Plus Health Information Heart Transplantation Social Bookmarking                   What's this?

ABO-incompatible heart transplantation: a perfusion strategy

Cardiovascular Perfusion Department, The Hospital for Sick Children, Toronto, Canada

C Gruenwald

Cardiovascular Perfusion Department, The Hospital for Sick Children, Toronto, Canada

L West

Cardiology Department, The Hospital for Sick Children, Toronto, Canada

Infants with fatal cardiac disease often die awaiting transplantation because of the shortage of donor hearts. The Hospital for Sick Children (HSC), Toronto, Canada, has researched and applied the concept of crossing the blood group compatibility barrier. Heart transplantation at HSC unrestricted by ABO compatibility greatly contributed to decreasing the mortality rate among infants on the waiting list from 58% to 10%.

From January 1996 to January 2002, 16 infants less than 14 months of age received ABO-incompatible heart transplants at our institution.

The cardiopulmonary bypass (CPB) circuit is primed with additional volume to replace the patient’s blood volume. Packed red blood cells (PRBC) used in priming must be ABO-compatible with the recipient. All plasma components and platelets must contain no anti-A or anti-B antibodies to donor or recipient. CPB is initiated and the patient’s venous blood is collected into a transfusion bag and sent to the blood bank. The total amount collected should be one and a half to two times the patient’s blood volume. The plasma is separated and discarded, returning only the PRBC, thus reducing the concentration of circulating antibodies to blood group antigens.

Our team has experienced an 87% survival rate with this technique. The success is believed to be associated with the recipients’ immunologic immaturity. Newborns do not produce isohemagglutinins, and serum anti-A and anti-B antibody titers usually remain low until 12-14 months of age. The complement system is not fully developed, therefore, the mediators of hyperacute rejection are absent during early infancy.

Heart transplantation unrestricted by the need for ABO compatibility would effectively expand the available donor pool and decrease waiting times.

Perfusion, Vol. 19, No. 1, 69-72 (2004)
DOI: 10.1191/0267659104pf708oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Alic, E. A. Akpek, A. Donmez, S. Ozkan, G. Y. Perfusionist, and S. Aslamaci ABO-Incompatible Blood Transfusion and Invasive Therapeutic Approaches During Pediatric Cardiopulmonary Bypass Anesth. Analg., October 1, 2008; 107(4): 1185 - 1187. [Abstract] [Full Text] [PDF]